1
Thijssen, Salina V., Boersma, Liesbeth J., Heising, Luca, Swart, Rachelle R., Ou, Carol, Roumen, Cheryl, Jacobs, Maria J. G.
Veröffentlicht in: Thijssen , S V , Boersma , L J , Heising , L , Swart , R R , Ou , C , Roumen , C & Jacobs , M J G 2023 , ' Clues to address barriers for access to proton therapy in the Netherlands ' , Radiotherapy and Oncology , vol. 178 , 109432 . https://doi.org/10.1016/j.radonc.2022.11.021;
2023
Veröffentlicht in: Thijssen , S V , Boersma , L J , Heising , L , Swart , R R , Ou , C , Roumen , C & Jacobs , M J G 2023 , ' Clues to address barriers for access to proton therapy in the Netherlands ' , Radiotherapy and Oncology , vol. 178 , 109432 . https://doi.org/10.1016/j.radonc.2022.11.021;
2023
2
Draeger, Teresa, Voelkel, Vinzenz, Groothuis-Oudshoorn, Catharina G. M., Lavric, Miha, Veltman, Jeroen, Dassen, Anneriet, Boersma, Liesbeth J., Witteveen, Annemieke, Sonke, Gabe S., Koffijberg, Hendrik, Siesling, Sabine
Veröffentlicht in: Draeger , T , Voelkel , V , Groothuis-Oudshoorn , C G M , Lavric , M , Veltman , J , Dassen , A , Boersma , L J , Witteveen , A , Sonke , G S , Koffijberg , H & Siesling , S 2020 , ' Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population : Consequences for Care and Costs ' , Value in Health , vol. 23 , no. 9 , pp. 1149-1156 . https://doi.org/10.1016/j.jval.2020.05.012;
2020
Veröffentlicht in: Draeger , T , Voelkel , V , Groothuis-Oudshoorn , C G M , Lavric , M , Veltman , J , Dassen , A , Boersma , L J , Witteveen , A , Sonke , G S , Koffijberg , H & Siesling , S 2020 , ' Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population : Consequences for Care and Costs ' , Value in Health , vol. 23 , no. 9 , pp. 1149-1156 . https://doi.org/10.1016/j.jval.2020.05.012;
2020
3
Draeger, Teresa, Voelkel, Vinzenz, Groothuis-Oudshoorn, Catharina G.M., Lavric, Miha, Veltman, Jeroen, Dassen, Anneriet, Boersma, Liesbeth J., Witteveen, Annemieke, Sonke, Gabe S., Koffijberg, Hendrik, Siesling, Sabine
Veröffentlicht in: Value in Health ; volume 23, issue 9, page 1149-1156 ; ISSN 1098-3015;
2020
Veröffentlicht in: Value in Health ; volume 23, issue 9, page 1149-1156 ; ISSN 1098-3015;
2020
4
5
de Wild, Sabine R., de Munck, Linda, Simons, Janine M., Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H.M., Houben, Ruud M.A., van Leeuwen, A. Elise, Linn, Sabine C., Pijnappel, Ruud M., Poortmans, Philip M.P., Strobbe, Luc J.A., Wesseling, Jelle, Voogd, Adri C., Boersma, Liesbeth J.
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
6
de Wild, Sabine R, de Munck, Linda, Simons, Janine M, Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H M, Houben, Ruud M A, van Leeuwen, A Elise, Linn, Sabine C, Pijnappel, Ruud M, Poortmans, Philip M P, Strobbe, Luc J A, Wesseling, Jelle, Voogd, Adri C, Boersma, Liesbeth J
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022